Although it was the COVID-19 pandemic that pushed decentralized clinical trials (DCTs) to the forefront, they had been around for nearly a decade. And while DCTs may increase access to and diversity in clinical trials, study sponsors must ensure participants are safe and protected, while maintaining data integrity.
When you hear DCT, you automatically think it’s going to be more convenient.
Citeline Connect
The end-to-end solution to find, educate, engage, and enroll clinical trial participants worldwide
Sitetrove
The industry-leading suite of global clinical trial investigator and site intelligence
Trial Portfolio Websites
The comprehensive solution for educating, engaging and enrolling participants across an entire clinical trial portfolio